Sharma Hari Shanker, Ali Syed F, Tian Z Ryan, Hussain Saber M, Schlager John J, Sjöquist Per-Ove, Sharma Aruna, Muresanu Dafin F
Laboratory of Cerebrovascular Research, Department of Surgical Sciences, Anaesthesiology and intensive Care Medicine, University Hospital, Uppsala University, SE-75185 Uppsala, Sweden.
J Nanosci Nanotechnol. 2009 Aug;9(8):5073-90. doi: 10.1166/jnn.2009.gr10.
The possibility that chronic exposure of nanoparticles may alter stress reaction and brain pathology following hyperthermia was examined in a rat model. Engineered nanoparticles from Ag or Cu (approximately equal to 50-60 nm) were administered (30 mg/kg, i.p.) once daily for 1 week in young male rats. On the 8th day these animals were subjected to 4 h heat stress at 38 degrees C in a BOD incubator. In these animals stress symptoms, blood-brain barrier (BBB) permeability, cognitive and motor functions and brain pathology were examined. Subjection of nanoparticle treated rats to heat stress showed exacerbation of stress symptoms i.e., hyperthermia, salivation and prostration and exhibited greater BBB disruption, brain edema formation, impairment of cognitive and motor functions and brain damage compared to normal animals. This enhanced brain pathology in heat stress was most marked in animals that received Ag nanoparticles compared to Cu treatment. Treatment with antioxidant compound H-290/51 either 30 min or 60 min after heat stress did not alter hyperthermia induce brain pathology in nanoparticle treated rats. Whereas, administration of nanowired-H-290/51 after 30 min or 60 min heat stress markedly attenuated BBB disruption, sensory motor function and brain pathology. These results suggest that chronic nanoparticles treatment exacerbate hyperthermia induced brain pathology that is significantly attenuated by nanowired but not normal H-290/51 compound. Taken together, our observations suggest that nano-wired drug delivery of H-290/51 is a promising approach to induce neuroprotection in hyperthermia induced brain pathology, not reported earlier.
在大鼠模型中研究了纳米颗粒长期暴露是否会改变热应激后的应激反应和脑病理。将来自银或铜的工程纳米颗粒(约50 - 60纳米)以30毫克/千克的剂量腹腔注射,在年轻雄性大鼠中每日给药一次,持续1周。在第8天,将这些动物置于BOD培养箱中在38摄氏度下进行4小时热应激。检测这些动物的应激症状、血脑屏障(BBB)通透性、认知和运动功能以及脑病理。与正常动物相比,纳米颗粒处理的大鼠经受热应激后应激症状加剧,即体温过高、流涎和虚脱,并且表现出更大的血脑屏障破坏、脑水肿形成、认知和运动功能受损以及脑损伤。与铜处理相比,在热应激中这种增强的脑病理在接受银纳米颗粒的动物中最为明显。在热应激后30分钟或60分钟用抗氧化化合物H - 290/51处理并没有改变纳米颗粒处理的大鼠中热应激诱导的脑病理。然而,在热应激30分钟或60分钟后给予纳米载药H - 290/51显著减轻了血脑屏障破坏、感觉运动功能和脑病理。这些结果表明,长期纳米颗粒处理会加剧热应激诱导的脑病理,而纳米载药但不是正常的H - 290/51化合物能显著减轻这种病理。综上所述,我们的观察结果表明,纳米载药H - 290/51是一种在热应激诱导的脑病理中诱导神经保护的有前景的方法,此前未见报道。